'Striking' Benefit of Lipid Lowering in Primary Prevention :

A new analysis has shown a particularly large reduction in CV events and death with lipid-lowering therapy in the primary prevention population, leading to calls for more attention to be paid to this group.

Related Keywords

Massachusetts , United States , Ohio , Cleveland , Boston , American , Agepha Pharma , Dhruvs Kazi , Steve Nissen , Drug Administration , American College Of Cardiology , Journal Of The American Medical Association , American Diabetes Association , Beth Israel Deaconess Medical Center , Heart Vascular Thoracic Institute At Cleveland Clinic , American College , Medscape Medical , Heart Vascular , Thoracic Institute , Cleveland Clinic , Scientific Sessions , American Medical , High Sensitivityc Reactive ,